Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Income from Continuing Operations
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
Income from Continuing Operations
¥487.2m
|
CAGR 3-Years
31%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Income from Continuing Operations
¥2.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Income from Continuing Operations
¥830.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
21%
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Income from Continuing Operations
¥1.3B
|
CAGR 3-Years
16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
Winner Medical Co Ltd
SZSE:300888
|
Income from Continuing Operations
¥628.5m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Income from Continuing Operations
¥1.7B
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
487.2m
CNY
Based on the financial report for Dec 31, 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd's Income from Continuing Operations amounts to 487.2m CNY.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
40%
Over the last year, the Income from Continuing Operations growth was 38%. The average annual Income from Continuing Operations growth rates for Shanghai MicroPort Endovascular MedTech Group Co Ltd have been 31% over the past three years , 40% over the past five years .